Medical Congress News
Medical Digest & Congress Report
The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.
Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: medicaldigest.org
Autor
Medical Congress News
Kategoria
Strona podcastu
Ostatni odcinek
20 lis 2026
Gdzie słuchać?
Podcasty w aplikacji Replaio Radio Już wkrótcePodcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów
Odcinki
Reprogramming the Immune Microenvironment to Intercept Lung Adenocarcinoma Precancer - report from SITC 2025 27.11.2025 3:46
Professor Jianjun Zhang shares his insights on reprogramming the immune microenvironment to intercept lung adenocarcinoma precancer at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:reprogramming-immune-microenvironment-intercept-lung-adenocarcinoma-precancer
Primary analysis of patients with high-risk localized, locally recurrent, or regionally advanced cutaneous squamous cell carcinoma treated with neoadjuvant PD-1 therapy - report from SITC 2025 27.11.2025 5:09
Professor Gino In presented data from the NeoPOWER trial, to study the role of neoadjuvant PD-1 alone in CSCC at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:primary-analysis-patients-high-risk-localized-locally-recurrent-or-regionally-advanced-cutaneous-squamous-cell-carcinoma-treated-neoadjuvant-pd-1-therapy
Phase I Trial of DOC1021 Cell-Based Immunotherapy for Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma - report from SITC 2025 27.11.2025 8:04
Professor William Decker discusses the Phase I Trial of DOC1021 cell-based immunotherapy for resectable or borderline resectable pancreatic ductal adenocarcinoma at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:phase-i-trial-doc1021-cell-based-immunotherapy-resectable-or-borderline-resectable-pancreatic-ductal-adenocarcinoma
How to optimize PD1/PDL1 treatment? - report from SITC 2025 27.11.2025 8:24
Professor Gordon J. Freeman shares his insights on how to optimize PD1/PDL1 treatment at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:how-optimize-pd1pdl1-treatment
Modulating the Tumor Microenvironment with T Cell Bispecifics - report from SITC 2025 27.11.2025 4:36
Professor Sumit K. Subudhi shares his insights on modulating the tumor microenvironment with T Cell bispecifics at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:modulating-tumor-microenvironment-t-cell-bispecifics
Comparative Cardioprotective Effects of GLP-1 Receptor Agonists versus SGLT2 Inhibitors in Pulmonary Arterial Hypertension: Insights from a Large-Scale Real-World data analysis 27.11.2025 7:03
Dr. Saud Alawad and Prof. Sunil Sharma discuss the comparative cardioprotective effects of GLP-1 receptor agonists versus SGLT2 inhibitors in pulmonary arterial hypertension after the American College of Chest Physicians (CHEST) 2025 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:comparative-cardioprotective-effects-glp-1-receptor-agonists-versus-sglt2-inhibitors-pu...
Ensifentrine treatment improves COPD symptoms and quality of life in a pooled analysis of the ENHANCE trials - report from CHEST 2025 27.11.2025 7:12
Professor Nicola Hanania discuss the lessons from the ENHANCE trials were presented at the American College of Chest Physicians (CHEST) 2025 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:ensifentrine-treatment-improves-copd-symptoms-and-quality-life-pooled-analysis-enhance-trials
Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s - report from CHEST 2025 27.11.2025 13:27
Dr. Cosmo Fowler explains thet data revealed one-year mortality in patients with type 2 diabetes prescribed GLP-1 RAs was substantially lower than those not prescribed the drugs, and disproportionate benefit for those also diagnosed with OSA. The results were presented at the American College of Chest Physicians (CHEST) 2025 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/inte...
Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis - report from AHA 2025 26.11.2025 8:36
Professor Paola Patrignani shares her insights on the advances in the development of therapeutic targets in the platelet for prevention of thrombosis at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:advances-development-therapeutic-targets-platelet-prevention-thrombosis
Long-term Efficacy and Safety of Lerodalcibep in the Open-label 72-week Extension Study of Subjects Previously on Inclisiran or Lerodalcibep in the LIBerate-VI Trial - report from AHA 2025 26.11.2025 4:03
Dr. Evan A Stein shares his insights on the emerging opportunities for managing cardiometabolic syndrome at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:long-term-efficacy-and-safety-lerodalcibep-open-label-72-week-extension-study-subjects-previously-inclisiran-or-lerodalcibep-liberate-vi-trial
2025 AHA Blood Pressure Guideline & CKD Management: Key Insights and Global Perspectives - report from AHA 2025 26.11.2025 8:51
Professor Eugene Yang shares his insights on the 2025 AHA Blood Pressure Guideline & CKD Management at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:2025-aha-blood-pressure-guideline-ckd-management-key-insights-and-global-perspectives-report-aha-2025
Lipid Lowering Therapies and Lipid Risk Factors - report from AHA 2025 26.11.2025 19:05
Professor Samia Mora explains her opinion on lipid lowering therapies and lipid risk factors at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:lipid-lowering-therapies-and-lipid-risk-factors
The New 2025 Guideline for Acute Coronary Syndromes - report from AHA 2025 26.11.2025 3:24
Professor Debabrata Mukherjee shares his insights on the Guideline for Acute Coronary Syndromes at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:new-2025-guideline-acute-coronary-syndromes
Aortic Regurgitation: The New Frontier - Imaging, Interventions, and the Future of Treatment - report from AHA 2025 26.11.2025 9:09
Professor Robert O. Bonow shares his insights on aortic regurgitation, imaging, interventions, and the future of treatment at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:aortic-regurgitation-new-frontier-imaging-interventions-and-future-treatment
Immuno-oncology biomarkers in locally advanced HNSCC - lessons from the KeyNote-689 trial - report from ESMO 2025 14.11.2025 5:37
Professor Cécile Badoual shares her thoughts on the immuno-oncology biomarkers in locally advanced HNSCC and explains the lessons from the KeyNote-689 trial after the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:immuno-oncology-biomarkers-locally-advanced-hnscc-lessons-keynote-689-trial
Novelties of the treatment of colon cancer at ESMO 2025 14.11.2025 6:13
Professor Julien Taieb shares his thoughts on the novelties of the treatment of colon cancer at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:novelties-treatment-colon-cancer-esmo-2025
How to PROC - Breaking the Wall of Platinum-Resistance in Ovarian Cancer - report from ESMO 2025 14.11.2025 8:43
Professor Jalid Sehouli explains how to break the wall of platinum-resistance in ovarian cancer at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:how-proc-breaking-wall-platinum-resistance-ovarian-cancer
IMvigor011: A Phase 3 Trial of ctDNA-Guided Adjuvant Atezolizumab versus Placebo in MIBC - report from ESMO 2025 14.11.2025 7:09
Professor Thomas B. Powles discuss the results from IMvigor011, a phase 3 trial of ctDNA-guided adjuvant atezolizumab versus placebo in muscle invasive bladder cancer were presented at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:imvigor011-phase-3-trial-ctdna-guided-adjuvant-atezolizumab-versus-placebo-mibc
T-DXd Effective for Treating HER2+ Advanced or Metastatic Breast Cancer, Regardless of Treatment History, HR Status, or PIK3C Mutations - report from ESMO 2025 14.11.2025 5:19
Professor Sibylle Loibl shares her thoughts on the additional analyses of DESTINY-Breast09 were presented at the ESMO Congress 2025. Key subgroup analysis of DESTINY-Breast09 confirms efficacy of trastuzumab deruxtecan plus pertuzumab for treating HER2+ advanced or metastatic breast cancer across groups. Video: https://medicaldigest.org/scientific-contents/interview:t-dxd-effective-treating-her2-a...
What's new in ESMO guidelines? - report from ESMO 2025 14.11.2025 6:26
Professor Emanuela Romano explains what's new in ESMO guidelines on hepatocellular carcinoma, cutaneous melanoma, Hodgkin Lymphomas and early stage and locally advanced non-small cell lung cancers at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:whats-new-esmo-guidelines
DYNAMIC-III trial results: ctDNA blood test is a powerful tool to guide treatment choices for people with advanced colon cancer - report from ESMO 2025 13.11.2025 6:18
Professor Jeanne Tie shares her thoughts on the DYNAMIC-III trial results were presented at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:dynamic-iii-trial-results-ctdna-blood-test-powerful-tool-guide-treatment-choices-people-advanced-colon-cancer
Overcoming Therapeutic Challenges in High-risk Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Approach - report from ESMO 2025 13.11.2025 7:09
Professor Dirk Schadendorf shares his thoughts on the overcoming therapeutic challenges in high-risk cutaneous squamous cell carcinoma at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:overcoming-therapeutic-challenges-high-risk-cutaneous-squamous-cell-carcinoma-multidisciplinary-approach
KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials - report from ESMO 2025 13.11.2025 4:14
Professor Christof Vulsteke shares her thoughts on the data from the phase 3 KEYNOTE-905 trial were presented at the ESMO Congress 2025. A treatment regimen consisting of neoadjuvant enfortumab vedotin-ejfv plus pembrolizumab, radical cystectomy plus pelvic lymph node dissection, and adjuvant EV plus pembrolizumab yielded significant improvements in multiple outcomes in patients with muscle-invasi...
Durvalumab in Combination with BCG for BCG-Naïve High-Risk NMIBC: Final Analysis of the Phase 3, Open-Label, Randomized POTOMAC Trial - report from ESMO 2025 13.11.2025 3:35
Professor Maria De Santis shares her thoughts on the final analysis of the phase 3, open-Label, randomized POTOMAC trial were presented at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:durvalumab-combination-bcg-bcg-naive-high-risk-nmibc-final-analysis-phase-3-open-label-randomized-potomac-trial
Treatment Landscape in Resectable LA HNSCC - report from ESMO 2025 13.11.2025 6:10
Professor Hisham M. Mehanna shares his thoughts on the treatment landscape in resectable LA HNSCC at ESMO 2005 at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:treatment-landscape-resectable-la-hnscc
Podobne podcasty
Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS